Genome and Company has acquired a majority stake in Scioto Biosciences following its contribution to a series B round that will be sized at up to $26.5m.

Utec has backed immunotherapy screening business ImmunoScape, which hopes to launch its product in the US and Japan.

The cancer treatment developer floated in the middle of its range following $175m in venture funding from investors including Novo.

YJ Capital and existing investor GV were among the partcipants in the latest round for metabolic disease treatment developer Fractyl.

Sinopharm Capital contributed to a series A-plus round raised two months after ABM began enrolling patients for a phase 1 trial of its cancer drug candidate.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The Müller Medien-backed telehealth diagnostics system developer raised $10.3m in a round co-led by Heal Capital and the European Bank for Reconstruction and Development.

Cyberdyne's CEJ Capital unit chipped into a round for the flu diagnostics device developer that hiked its overall funding to $27.5m.

A consortium of 15 startups were chosen to take part in the first edition of the internet technology group’s regional accelerator scheme, which will run until November this year.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.